Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra.

We report on the magnetic resonance spectroscopy (MRS) characterisation of different human meningiomas. Three histological subtypes of meningiomas (meningothelial, fibrous and oncocytic) were analysed both through in vivo and ex vivo MRS experiments. The ex vivo high-resolution magic angle spinning (HR-MAS) investigations, permitting an accurate description of the metabolic profile, are very helpful for the assignment of the resonances in vivo of human meningiomas and for the validation of the quantification procedure of in vivo MR spectra. By using one- and two-dimensional experiments, we were able to identify several metabolites in different histological subtypes of meningiomas. Our spectroscopic data confirmed the presence of the typical metabolites of these benign neoplasms and, at the same time, that meningomas with different morphological characteristics have different metabolic profiles, particularly regarding macromolecules and lipids. The ex vivo spectra allowed a better understanding and interpretation of the in vivo MR spectra, showing that the HR-MAS MRS technique could be a complementary method to strongly support the in vivo MR spectroscopy and increase its clinical potentiality.

[1]  R. R. Ernst,et al.  Two‐dimensional spectroscopy. Application to nuclear magnetic resonance , 1976 .

[2]  Wei Li,et al.  Methods for acquisition and assignment of multidimensional high-resolution magic angle spinning NMR of whole cell bacteria. , 2005, Analytical chemistry.

[3]  Margarida Julià-Sapé,et al.  Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. , 2004, AJNR. American journal of neuroradiology.

[4]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[5]  F. Howe,et al.  Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS , 2003, Magnetic resonance in medicine.

[6]  Gi-Hwan Choi,et al.  (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. , 2003, Magnetic resonance imaging.

[7]  A. Bax A spatially selective composite 90° radiofrequency pulse , 1985 .

[8]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[9]  V. Eusebi,et al.  Oncocytic meningioma. , 1997, The American journal of surgical pathology.

[10]  G. Bodenhausen,et al.  Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy , 1980 .

[11]  P. Carroll,et al.  Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.

[12]  W. Zimmermann,et al.  Two-step enzymatic synthesis of maltooligosaccharide esters. , 2000, Carbohydrate research.

[13]  S. Meiboom,et al.  Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .

[14]  T. Bathen,et al.  Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[15]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[16]  T. Bathen,et al.  5 – High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy , 2008 .

[17]  Franklyn A. Howe,et al.  Comparison of in vivo1H MRS of human brain tumours with1H HR-MAS spectroscopy of intact biopsy samples in vitro , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.

[18]  Richard R. Ernst,et al.  Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy , 1983 .

[19]  R. Dawson,et al.  Building Biosynthetic Schools: Reviewing Compartmentation of CNS Taurine Synthesis , 2004, Neurochemical Research.

[20]  D. Cory,et al.  Gradient, high‐resolution, magic‐angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue , 1997, Magnetic resonance in medicine.

[21]  M. Hartmann,et al.  Characterization of necrotic meningioma using diffusion MRI, perfusion MRI, and MR spectroscopy: case report and review of the literature , 2004, Neuroradiology.

[22]  L. Martí-Bonmatí,et al.  1H and 13C HR‐MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas , 2004, NMR in biomedicine.

[23]  V. Castronovo,et al.  Reduced glutathione system: role in cancer development, prevention and treatment (review). , 2001, International journal of oncology.

[24]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[25]  A. Häkkinen,et al.  High‐resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3 , 2004, Journal of neuroscience research.

[26]  Y. Kinoshita,et al.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.

[27]  M. Leonardi,et al.  Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms. , 1998, Oncology reports.

[28]  N. Heaton,et al.  Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. , 2005, Analytical chemistry.

[29]  S. Williams,et al.  Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. , 1995, Cancer research.

[30]  G. Balendiran,et al.  The role of glutathione in cancer , 2004, Cell biochemistry and function.

[31]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[32]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Arús,et al.  Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas , 2003, Neuroradiology.

[34]  F. Tavani,et al.  A comparison between in vivo and ex vivo HR-MAS 1H MR spectra of a pediatric posterior fossa lesion. , 2005, International journal of molecular medicine.

[35]  Mathias Hoehn,et al.  Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation , 2005, NMR in biomedicine.

[36]  Charles S. Johnson,et al.  An Improved Diffusion-Ordered Spectroscopy Experiment Incorporating Bipolar-Gradient Pulses , 1995 .

[37]  K. Wüthrich,et al.  Carbon‐13 NMR chemical shifts of the common amino acid residues measured in aqueous solutions of the linear tetrapeptides H‐Gly‐Gly‐ X‐L‐ Ala‐OH , 1978 .

[38]  D. Townsend,et al.  The role of glutathione-S-transferase in anti-cancer drug resistance , 2003, Oncogene.

[39]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[40]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .